DOJ Marijuana Lawsuit Filing Cites Drug Testing Industry And Pharma Company ‘Pocketbook Interests’ In Opposing Rescheduling
The Department of Justice filed a legal brief arguing against a motion to pause the Trump administration's cannabis rescheduling proposal, contending that drug testing industry groups and pharmaceutical companies opposing the reform are motivated by financial interests rather than public health concerns.
Filed under Court Ruling in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
Trump Is Being Sued For Rescheduling Marijuana By Doctors And A Pharmaceutical Company Who Are ‘Aggrieved’ By The Move
State Attorneys General File Lawsuit To Block Trump Administration’s Marijuana Rescheduling Move
Marijuana Opponents File Lawsuit To Block Trump Administration’s Federal Rescheduling Move
Federal Marijuana Rescheduling Shouldn’t Impact Case On Gun Rights For Users, Trump DOJ Says In Supreme Court Filing
Marijuana Rescheduling Appeal Process ‘Remains Pending’ Despite Trump’s Executive Order, DEA Says In New Filing
Federal Judge Dismisses Anti-Marijuana Groups’ Lawsuit Challenging Medicare Hemp Coverage Program
Stay current on Minnesota cannabis
Browse more court ruling updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.